Alpha-fetoprotein (AFP) is a mammalian embryo-specific protein, also known as a tumor marker and could be found in some cases of liver and reproductive system cancers 1 . Human AFP (AFPh) is a 70 kDa glycoprotein containing up to 4 % of carbohydrates. It is a transport protein possessing strong conjugating features. It is known that some receptors of tumor cells are AFP ligands 2 . This feature is used for the targeted delivery of cytostatic and cytotoxic drugs into malignant cells 3, 4, 5, 6, 7 . Development of the drugs inducing apoptosis in the tumor cells is one of the perspective directions in oncology. The ability of the AFPh to induce apoptosis and to inhibit growth of some tumors by expression of the p53 gene were shown in several researches 8, 9, 10, 11, 12, 13, 14 .
Alternatively, AFP conjugation with antisense oligonucleotides to the mRNAs of the genes participating in cell proliferation and apoptosis could make sense. AFP conjugate with an antisense oligonucleotide for the mRNA of the antiapoptotic bcl-2 gene induced apoptosis and subsequent death of the tumor cells 15 . Thus, biological features of the AFPh offers great opportunities to develop various anticancer drugs that could be highly selective to the tumor cells. However, this promising perspective is limited to the complexity and the cost of the AFPh purification from the abortion serum. Recombinant systems producing AFPh could be the solution.
The aims of this work were AFPh gene cloning and optimization of its expression in a plant in vitro system.
MATERIALS AND METHODS
Human hepatocellular carcinoma (HepG2) cell line was used as a DNA source RNA was purified by commercial "RNAqueous®" kit using manufacturer's guide (Ambion).
The revers transcription reaction was driven by the use of the moloney murine leukemia virus reverse transcriptase (M-MLV RT) (Thermo Scientific). The subsequent polymerase chain reaction was directed by the PL polymerase (Syntol). DNA cloning was performed according to 16 DNA sequencing by Sanger was made in "ABI PRISM 3101 Genetic Analyzer" (Applied Biosystems) using "BigDye® Terminator v3. 
In vitro transcription
In vitro transcription by the T7 RNApolymerase according to 17 . 50 µL of the reaction mix contained 40 mM Tris-HCl (pH 7.9), 6 mM MgCl 2 , 10 mM DTT, 10 mM NaCl, 2 mM spermidin, 2 mM of each ribonucleoside triphosphate, 40 units of the ribonuclease inhibitor, 40 units of the T7 RNA-polymerase and 1 µg of DNA. The reaction lasted 2 hours at 37°C. Then the reaction mix was treated with chloroform. RNA precipitated in the presence of 3M LiCl. The pellet was washed with 70% ethanol after centrifugation at 14000 RPM.
Dried under vacuum the pellet was dissolved in H 2 O. RNA concentration was determined by spectrophotometry.
In vitro translation
In vitro translation was carried out in the wheat germ cell-free system from the "Kazakhstanskaya 4" variety 18 . 25 µL of the reaction mix contained 20 mM Tris-Ac (pH 7.6), 90 mM KAc, 2 mM MgAc 2 , 10 mM phosphocreatine, 0.12 mg/mL creatine phosphokinase, 1 19 . The gel was dried and subsequent autoradiography using "Kodak" X-ray film was made. Western blot analysis was made according to 20 . Antibodies conjugated to horseradish peroxidase were used as a secondary to AFPh-specific monoclonal antibodies.
RESULTS AND DISSCUSSION
AFP gene belongs to the albumin gene family and located in the long arm of the fourth chromosome (4q11-q13) 21 . Like all secreted proteins, AFP is synthesized as a precursor, which becomes the mature protein after cleavage of the signal peptide and the process of glycosylation. The complete nucleotide sequence of the AFP gene is known. It consists of 20000 base pairs, contains 15 exons and 14 introns 22 . Nucleotide sequence of the AFP mRNA consists of 2098 nucleotides and has three main parts: 44 noncoding nucleotides at the 5'-end, 1830 coding and 155 noncoding nucleotides at the 3'-end 23 . The signal peptide consists of 19 amino acids followed by 590 amino acids of the mature protein.
Thus, taking into account big size of the AFPh gene and many introns inside it seems impossible to express it neither in vitro nor in vivo in bacterial or plant systems. We decided to clone complementary DNA (cDNA) of the AFPh gene. mRNA sequence of the AFPh (GenBank: NM_001134) was analyzed with SnapGene® software (GSL Biotech) to build DNA restriction map. These data were used to design oligonucleotide primers. Total RNA was purified from the AFPh producing human hepatocellular carcinoma (HepG2) cell line (Fig. 1) . It is seen from the Fig. 1 that 28S , 18S ribosomal RNAs and 4S transport RNA (about 100 nucleotides) are major components of the sample. The RNA sample was enriched by highly weight molecular components after precipitation by 3M LiCl, since low weight tRNA molecules was leaved in the supernatant fraction (lane 2).
Obtained RNA sample was used to synthesize cDNA of the AFPh by moloney murine leukemia virus reverse transcriptase with the use of antisense primer no.1 (5'GCATCTC GAGTTAAACTCC CAAAGCAGCA CGAG TTTTTG) containing XhoI restriction site (underlined). Antisense oligonucleotide primer no.1 and sense oligonucleotide primer no.2 (5'GCAACCATGGAGTGGGTGGAATC), containing NcoI restriction site (underlined) were used to amplify the resulting cDNA. We performed 30 cycles of the following PCR program: 30 seconds at 94°C (initial denaturing lasted 4 minutes), 30 seconds at 48°C and 1 minute at 72°C (final elongation lasted 5 minutes). Results of the RT-PCR are represented in the Fig. 2. [ Figure 2 ] Electrophoregram shows resulting 2000 bp DNA amplification products presumably coding AFPh protein 2000 bp fragments obtained were eluted from the gel and cloned into series of bacterial pIVEX-WG-1.3 vectors between NcoI-XhoI restriction sites under the control of the T7 bacteriophage promoter. The plasmids of this series differ from the analogous vectors constructs by the presence of the translational enhancers described earlier 24 . In addition, it is possible to insert various 5'-untranslating regions between HindIII-NcoI restriction sites to test if it increases efficiency of the mRNA translation.
The resulting recombinant plasmids, containing AFPh gene are schematically represented in the Fig. 3 .
We performed DNA sequencing of the cloned AFPh gene from the 3'-end (about 500 nucleotides). Comparative Blast-analysis identified the sequence as AFPh mRNA from the NCBI "Nucleotide" database (www.ncbi.nlm.nih.gov).
Thus, we developed three types of the recombinant plasmids that could be transcribed by the T7 RNA-polymerase and differing only in the structure of the 5'-UTR.
In subsequent experiments, the plasmids were linearized with EcoRI enzyme, which unique restriction site is situated after the 3'-UTR of the TMV genomic RNA. This linearized plasmids served as a template for in vitro transcription from T7 promoter. Equal amounts of uncapped mRNAs synthesized by the T7 RNA-polymerase were used as a templates for in vitro translation in the wheat germ cell-free system. Proteins translated in vitro in the presence of the [ 
